Ensol Biosciences Inc. (XKON:140610)
South Korea · Delayed Price · Currency is KRW 12,770
+520 (4.24%)
At close: Jun 5, 2026
Ensol Biosciences Market Cap
Ensol Biosciences has a market cap or net worth of 168.65 billion as of June 5, 2026. Its market cap has decreased by -41.53% in one year.
Market Cap
168.65B
Enterprise Value
n/a
Revenue
537.46M
Ranking
n/a
PE Ratio
n/a
Stock Price
12,770.00
Market Cap Chart
Since September 10, 2018, Ensol Biosciences's market cap has increased from 106.21B to 168.65B, an increase of 58.79%. That is a compound annual growth rate of 6.16%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jun 5, 2026 | 172.98B | -1.48% |
| Dec 30, 2025 | 175.59B | -10.18% |
| Dec 30, 2024 | 195.49B | 264.72% |
| Dec 28, 2023 | 53.60B | -23.21% |
| Dec 29, 2022 | 69.80B | -47.06% |
| Dec 30, 2021 | 131.85B | 5.52% |
| Dec 30, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
| Sep 10, 2018 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Kangstem Biotech | 247.83B |
| Y-Biologics | 225.39B |
| NIBEC | 221.56B |
| Genome & Company | 195.98B |
| ViGenCell | 194.74B |
| TiumBio | 186.54B |
| Bio Solution | 180.37B |
| ABION | 158.85B |